FPT-SOFTWARE
Global tech corporation FPT affirms its position as a world-class technology enabler for complex business challenges and opportunities with long-term goals defined for 2024 onwards. FPT aims to achieve USD 5 billion in revenue from global IT services in 2030 and reach billion-dollar milestones from a single market, a single vertical industry, and a single contract.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240111379315/en/
From left to right: FPT Software Chairwoman Chu Thi Thanh Ha, FPT CEO Nguyen Van Khoa, FPT Software CEO Pham Minh Tuan (Photo: Business Wire)
On track with this direction, FPT recently became the first Vietnam-headquartered tech firm to surpass one billion USD in revenue from global IT services in 2023. The company embarked on the global expansion journey with the establishment of its subsidiary FPT Software in 1999. Since then, FPT has evolved from developing simple applications to implementing core IT services for its clients; transitioned from a services provider to a comprehensive solution provider; and progressed to higher stages in the technology value chain, with digital transformation and legacy modernization included in its offerings. To achieve its future goals, FPT will leverage its strengths in technical expertise and industry know-how, skilled IT talents, and the growing prominence of its home country Vietnam.
"In the past, FPT had to proactively seek partnerships, but now many big corporations are heading to Vietnam and FPT. Vietnam is rising as a new destination for global businesses. As Vietnam’s pioneering IT firm, we want to reach new heights in the semiconductor industry and artificial intelligence (AI). The future of Vietnam and the world will revolve around semiconductors and AI,” said FPT Chairman Dr. Truong Gia Binh.
"At FPT Software, we believe that world-class stature is built from world-class people. Over the past 25 years, we have strengthened the company's foundation by fostering a one-team spirit, a lifelong learning culture, and a happy working environment. Moving forward, we will continue promoting the development of technology, creativity, domain expertise, and embrace culture and diversity for our workforce of 30,000 talented individuals to keep up with growing market demand and global standards," said FPT Software Chairwoman Chu Thi Thanh Ha.
"Entering the new era as a world-class company, FPT Software is well-positioned to accompany our clients in projects worth millions or billions of dollars. We are committed to developing our high quality global IT workforce to better serve businesses in high-growth fields such as automotive, healthcare, insurance, supply chain, finance, and utilities. We will also embed AI into all services and solutions to enhance agility, productivity, quality and accelerate delivery time for our clients worldwide,” said FPT Software CEO Pham Minh Tuan.
With a track record of success and extensive experience gained over the years, FPT has established itself as a trusted partner to drive advancements in fast-growing fields. In 2023, FPT is one of three companies in Southeast Asia to join SAP’s Regional Strategic Services Partner (RSSP) in the Asia Pacific and Japan region. With over 10 years of experience in automotive software, FPT has built a strong team of over 4,000 engineers and experts for this domain, serving more than 150 clients, including renowned global brands such as Honda, Hyundai, Volvo, VinFast, Ford, Yazaki, LG, Panasonic, NXP. In December 2023, the subsidiary FPT Automotive was officially launched in the United States, after maintaining a growth rate of 40% in recent years as a unit under FPT Software, contributing significantly to its achievement of one billion USD in revenue from the global IT services segment.
About FPT Corporation and FPT Software
FPT Corporation is a global technology corporation and a leader in consulting, providing, and deploying technology and telecommunications services and solutions.
FPT Software, a subsidiary of FPT Corporation, is a global technology and IT services provider headquartered in Vietnam, with $1 billion in revenue (2023) and over 30,000 employees in 30 countries.
The company champions complex business opportunities and challenges with its world-class services in Advanced Analytics, AI, Digital Platforms, Cloud, Hyperautomation, IoT, Low-code, and so on. It has partnered with over 1,000+ clients worldwide, 91 of which are Fortune Global 500 companies in Aviation, Automotive, Banking, Financial Services and Insurance, Healthcare, Logistics, Manufacturing, Utilities, and more. For more information, please visit https://fptsoftware.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240111379315/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom